| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/21/2023 | 25.61% | Benchmark | → $18 | Reiterates | → Buy |
| 02/17/2023 | -2.3% | Credit Suisse | $12 → $14 | Maintains | Neutral |
| 02/17/2023 | 18.63% | RBC Capital | $14 → $17 | Upgrades | Sector Perform → Outperform |
| 02/13/2023 | 25.61% | Benchmark | → $18 | Reiterates | → Buy |
| 10/20/2022 | 25.61% | Benchmark | → $18 | Upgrades | Hold → Buy |
| 10/20/2022 | -16.26% | Credit Suisse | $15 → $12 | Maintains | Neutral |
| 10/20/2022 | -2.3% | RBC Capital | $17 → $14 | Maintains | Sector Perform |
| 04/21/2022 | 25.61% | Credit Suisse | $17 → $18 | Maintains | Neutral |
| 04/21/2022 | 39.57% | RBC Capital | $17 → $20 | Maintains | Sector Perform |
| 02/10/2022 | -5.79% | Jefferies | $19 → $13.5 | Downgrades | Hold → Underperform |
| 10/22/2021 | 53.52% | Credit Suisse | $28 → $22 | Maintains | Neutral |
| 10/21/2021 | 39.57% | RBC Capital | $29 → $20 | Maintains | Sector Perform |
| 10/20/2021 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 07/22/2021 | 102.37% | RBC Capital | $30 → $29 | Maintains | Sector Perform |
| 02/11/2021 | 116.33% | Credit Suisse | $32 → $31 | Maintains | Neutral |
| 10/22/2020 | 81.44% | Credit Suisse | $31 → $26 | Maintains | Neutral |
| 07/23/2020 | 102.37% | Baird | → $29 | Downgrades | Outperform → Neutral |
| 07/07/2020 | — | Northland Capital Markets | Downgrades | Outperform → Market Perform | |
| 07/06/2020 | — | Benchmark | Downgrades | Buy → Hold | |
| 04/22/2020 | 88.42% | Credit Suisse | $32 → $27 | Maintains | Outperform |
| 04/22/2020 | 46.55% | RBC Capital | $26 → $21 | Maintains | Sector Perform |
| 04/20/2020 | 95.39% | Baird | → $28 | Upgrades | Neutral → Outperform |
| 11/22/2019 | 81.44% | RBC Capital | → $26 | Initiates Coverage On | → Sector Perform |
| 10/23/2019 | 137.26% | Benchmark | $37 → $34 | Reiterates | → Buy |
| 07/24/2019 | 200.07% | Sidoti & Co. | $51 → $43 | Maintains | Buy |
| 07/24/2019 | 144.24% | Credit Suisse | $41 → $35 | Maintains | Outperform |
| 07/12/2019 | 123.31% | Jefferies | $40 → $32 | Downgrades | Buy → Hold |
| 05/01/2019 | 109.35% | Stifel | $33 → $30 | Maintains | Sell |
| 07/18/2018 | 144.24% | Stifel | $44 → $35 | Downgrades | Hold → Sell |
| 06/27/2018 | 269.85% | Jefferies | $40 → $53 | Upgrades | Hold → Buy |
| 06/12/2018 | 248.92% | Benchmark | → $50 | Initiates Coverage On | → Buy |
| 06/06/2018 | — | William Blair | Upgrades | Market Perform → Outperform | |
| 04/18/2018 | 234.96% | Credit Suisse | $62 → $48 | Maintains | Outperform |
| 04/18/2018 | 207.05% | Baird | $48 → $44 | Maintains | Neutral |
| 04/18/2018 | — | Stifel | Downgrades | Buy → Hold | |
| 04/17/2018 | 234.96% | Baird | $50 → $48 | Maintains | Neutral |
What is the target price for Healthcare Services Group (HCSG)?
The latest price target for Healthcare Services Group (NASDAQ: HCSG) was reported by Benchmark on February 21, 2023. The analyst firm set a price target for $18.00 expecting HCSG to rise to within 12 months (a possible 25.61% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthcare Services Group (HCSG)?
The latest analyst rating for Healthcare Services Group (NASDAQ: HCSG) was provided by Benchmark, and Healthcare Services Group reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Healthcare Services Group (HCSG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Services Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Services Group was filed on February 21, 2023 so you should expect the next rating to be made available sometime around February 21, 2024.
Is the Analyst Rating Healthcare Services Group (HCSG) correct?
While ratings are subjective and will change, the latest Healthcare Services Group (HCSG) rating was a reiterated with a price target of $0.00 to $18.00. The current price Healthcare Services Group (HCSG) is trading at is $14.33, which is within the analyst's predicted range.